Metformin Attenuates Myocardial Ischemia–Reperfusion Injury in Rats by Modulating JNK Pathway and Inhibiting PANoptosis Mechanisms
Cardiovascular Therapeutics · 2025-01 · 2025 (1)
DOI: 10.1155/cdr/4642838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 07.10.2025. Verfasst von Biao Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Coronary Artery Disease Surgical Center, Capital Medical University Affiliated Anzhen Hospital, Beijing, China. Hauptthemen laut MEDLINE: Metformin, Myocardial Reperfusion Injury, Myocardial Infarction, JNK Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
Myocardial ischemia–reperfusion injury (MIRI) is a condition in which the heart is aggravated when blood flow is restored after tissue damage caused by ischemia. Metformin (Met), a widely prescribed antidiabetic medication, has demonstrated promising cardioprotective properties, particularly through its anti‐inflammatory, antiapoptotic, and metabolic regulatory mechanisms. This study investigates the cardioprotective effects of Met in a rat model of MIRI, focusing on its modulation of the c‐Jun N‐terminal kinase (JNK) pathway and inhibition of PANoptosis mechanisms.
Methods
The proportion of myocardial infarction was determined by triphenyl tetrazole chloride (TTC) staining. Wheat germ agglutinin (WGA) staining is used to determine whether myocardial cells are hypertrophic and other pathological conditions. Serum markers of myocardial injury along with inflammatory cytokines were measured by enzyme‐linked immunosorbent assay (ELISA). Immunofluorescence and Western blotting were employed to evaluate myocardial cell PANoptosis and the involvement of the JNK pathway.
Results
After MIRI, TTC staining revealed apparent myocardial infarction, and WGA staining showed significant myocardial cell hypertrophy. There was also a marked increase in myocardial injury markers, inflammatory factors, and reactive oxygen species (ROS). Met significantly reduced the myocardial injury area and notably lowered serum levels of c‐TnI, CK‐MB, LDH, IL‐6, TNF‐ α , and ROS. Immunofluorescence and Western blot analyses demonstrated that Met attenuates myocardial cell PANoptosis by inhibiting JNK phosphorylation and reducing ROS generation. The cardioprotective effect of Met was reversed by the addition of anisomycin (ANI). The protective effect of JNK‐specific inhibitors administered as monotherapy was found to be comparable to that of Met. The aforementioned results suggest that the regulation of the JNK pathway is a critical factor contributing to its protective effect.
Conclusion
The cardioprotective effect of Met in the rat model of MIRI is mediated through the regulation of the JNK pathway and PANoptosis. These findings suggest that Met may provide a potential therapeutic approach for treating MIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Coronary Artery Disease Surgical Center, Capital Medical University Affiliated Anzhen Hospital, Beijing, China.
- Capital Medical University, Beijing, China.
- Cardiac Surgery Center, Capital Medical University Xuanwu Hospital, Beijing, China.
- The Key Laboratory of Remodeling Cardiovascular Diseases, Ministry of Education, Beijing, China.
- Collaborative Innovation Center for Cardiovascular Disorders, Beijing, China.
- Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hou, B., Hou, X., Zhang, L., Liu, T., Li, Y., & Dong, R. (2025). Metformin Attenuates Myocardial Ischemia–Reperfusion Injury in Rats by Modulating JNK Pathway and Inhibiting PANoptosis Mechanisms. Cardiovascular Therapeutics, 2025(1). https://doi.org/10.1155/cdr/4642838
Vancouver
Hou B, Hou X, Zhang L, Liu T, Li Y, Dong R. Metformin Attenuates Myocardial Ischemia–Reperfusion Injury in Rats by Modulating JNK Pathway and Inhibiting PANoptosis Mechanisms. Cardiovascular Therapeutics. 2025;2025(1). doi:10.1155/cdr/4642838
BibTeX
@article{Hou2025,
author = {Hou, Biao and Hou, Xuejian and Zhang, Liyue and Liu, Tingting and Li, Yang and Dong, Ran},
title = {Metformin Attenuates Myocardial Ischemia–Reperfusion Injury in Rats by Modulating JNK Pathway and Inhibiting PANoptosis Mechanisms},
journal = {Cardiovascular Therapeutics},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/cdr/4642838}
}
EUVIMED